Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Redi-Dri™ for Free-Flowing Hygroscopic Powders

Redi-Dri packaging system eliminates clumping typically noted with many hygroscopic powders and provides a free-flowing, ready-to-use material.

Contact Us

Customer Service: 27 11 979 1188

Web Toolbox

Our Web Toolbox features helpful online science research tools and resources

New Email Subscription Center

To receive the information that is relevant to your work, explore our new subscription center and set your preferences

About Us

Our life science business features a portfolio of more than 300,000 products enabling scientific discovery.

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

Darmstadt, Germany - August 19, 2019 Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

Read More
Darmstadt, Germany - August 6, 2019 Merck KGaA, Darmstadt, Germany Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

Merck KGaA, Darmstadt, Germany has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

Read More
Shanghai, China - July 24, 2019 Merck KGaA, Darmstadt, Germany to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

Merck KGaA, Darmstadt, Germany today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

Read More